01 2AURORIUM LLC
02 1Apotheca Company
01 1Colloidal Sulfur
02 1Sulfur
03 1Sulphur
01 3U.S.A
NDC Package Code : 57520-1245
Start Marketing Date : 2014-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 25441-0100
Start Marketing Date : 2020-02-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 25441-0110
Start Marketing Date : 2020-02-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (45kg/45kg)
Marketing Category : BULK INGREDIENT
A SULFUR manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of SULFUR, including repackagers and relabelers. The FDA regulates SULFUR manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. SULFUR API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A SULFUR supplier is an individual or a company that provides SULFUR active pharmaceutical ingredient (API) or SULFUR finished formulations upon request. The SULFUR suppliers may include SULFUR API manufacturers, exporters, distributors and traders.
click here to find a list of SULFUR suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing SULFUR as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for SULFUR API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture SULFUR as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain SULFUR and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a SULFUR NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of SULFUR suppliers with NDC on PharmaCompass.
LOOKING FOR A SUPPLIER?
